SCHEMBL485668

SCHEMBL485668

O=C(NC1CCCC1)c1ccc2ccccc2c1OCc1ccc(C(F)(F)F)cn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR2 P25025 1/20 0.47
DRD4 P21917 3/20 0.46
MAPT P10636 2/20 0.44
LMNA P02545 1/20 0.44
POLB P06746 1/20 0.44
HCRTR1 O43613 3/20 0.43
SCN7A Q01118 1/20 0.43
KCNH2 Q12809 1/20 0.43
SCN5A Q14524 1/20 0.43
SCN9A Q15858 1/20 0.43
MRGPRX4 Q96LA9 2/20 0.42
RAB9A P51151 2/20 0.42
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
MAOB P27338 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
KMT2A Q03164 1/20 0.41
ALOX5AP P20292 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL485687 0.87 MRGPRX4 (0.45) MAPTLMNAPOLBHCRTR1SCN7A
SCHEMBL485511 0.86 CXCR2 (0.62) CXCR2DRD4MRGPRX4CNR1CNR2
SCHEMBL485826 0.86 MRGPRX4 (0.51) MAPTLMNAPOLBHCRTR1MRGPRX4
SCHEMBL485799 0.85 MRGPRX4 (0.45) MAPTLMNAPOLBHCRTR1SCN7A
SCHEMBL485699 0.84 CXCR2 (0.62) CXCR2DRD4MRGPRX4CNR1CNR2
Formic Acid SCHEMBL27693250 0.83 MRGPRX4 (0.43) MAPTLMNAPOLBHCRTR1SCN7A
SCHEMBL485934 0.82 CXCR2 (0.47) CXCR2DRD4MAPTLMNAPOLB
SCHEMBL485472 0.82 CXCR2 (0.56) CXCR2HCRTR1RAB9AALOX5AP
SCHEMBL485579 0.81 CXCR2 (0.47) CXCR2DRD4MAPTRAB9ACNR1
Formic Acid SCHEMBL27713047 0.81 CXCR2 (0.58) CXCR2DRD4MRGPRX4CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836158-B1 FUSED BICYCLIC CARBOXAMIDE DERIVATIVES FOR USE AS CXCR2 INHIBITORS IN THE TREATMENT OF INFLAMMATION SANOFI AVENTIS DEUTSCHLAND (DE) 2012-02-01 EP claimed